• Cleerly expanded enrollment for its TRANSFORM clinical trial by deploying a cardiac-capable mobile CT scanner across the southern US.
• From July through September 2026, the unit reached underserved communities lacking cardiac CT, widening access to imaging-based trial participation.
• The trial is testing whether treatment guided by coronary artery disease staging can prevent heart attacks; no study results were reported.
• Clear Heart and Lung Imaging operated the mobile unit, positioning the program as a scale-up in trial recruitment infrastructure.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cleerly Inc. published the original content used to generate this news brief on October 08, 2026, and is solely responsible for the information contained therein.